Jiyoye
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_1317
|
Homo sapiens (Human)
|
EBV-related Burkitt lymphoma
|
Virology: Contains a complete EBV genome (strain Jiyoye) which has been sequenced (PubMed=25787276)., Population: African; Nigerian., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1915267
PMID:2998993
PMID:3026973
PMID:3518877
PMID:4169243
PMID:4321017
PMID:4321974
PMID:4736620
PMID:4894370
PMID:5260617
PMID:5786183
PMID:6018567
PMID:6231253
PMID:6500159
PMID:7316467
PMID:8108117
PMID:8515068
PMID:9473234
PMID:17254797
PMID:20164919
PMID:20215515
PMID:20454443
PMID:25485619
PMID:25787276
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
JIYOYE, Jijoye, JIJOYE, P-2003, P3 (Jiyoye), P-3-Jijoye, P3-Jiyoye, P-3J, P3J, Jiyoye(P-2003), Jiyoye (P-2003), JiyoyeP-2003, JIYOYEP2003, OB2, GM04678 |
|
|
CLO:CLO_0007025,
CLO:CLO_0019011,
EFO:EFO_0002215,
CLDB:cl2945,
CLDB:cl2946,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-87,
ATCC:CRL-7933,
BioGRID_ORCS_Cell_line:270,
BioSample:SAMN01821570,
BioSample:SAMN01821640,
BioSample:SAMN03471289,
cancercelllines:CVCL_1317,
Cell_Model_Passport:SIDM00808,
ChEMBL-Cells:CHEMBL3307658,
ChEMBL-Targets:CHEMBL614588,
CLS:300366,
Coriell:GM04678,
Cosmic:687846,
Cosmic:907268,
Cosmic:931105,
Cosmic:1818344,
Cosmic:2822950,
Cosmic-CLP:907268,
DepMap:ACH-002252,
DSMZ:ACC-590,
DSMZCellDive:ACC-590,
ECACC:88071302,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:907268,
GEO:GSM1669960,
IARC_TP53:702,
IGRhCellID:Jiyoye,
IZSLER:BS TCL 32,
KCLB:10087,
LINCS_LDP:LCL-2021,
NCBI_Iran:C117,
PharmacoDB:Jiyoye_703_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1317,
PubChem_Cell_line:CVCL_1317,
Wikidata:Q54898929 |
|
|
CVCL_1317 |
2026-08-15 04:43:53 |
3 |
JM-1
Resource Report
Resource Website
|
RRID:CVCL_3532
|
Homo sapiens (Human)
|
B acute lymphoblastic leukemia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2647717
PMID:9067587
PMID:20215515
PMID:22460905
PMID:26589293
PMID:27397505
PMID:30285677
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Male |
JM1 |
|
|
CLO:CLO_0007030,
EFO:EFO_0002212,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-10423,
BCRC:60513,
BioSample:SAMN03471300,
BioSample:SAMN10987951,
cancercelllines:CVCL_3532,
Cell_Model_Passport:SIDM00689,
ChEMBL-Cells:CHEMBL3308496,
ChEMBL-Targets:CHEMBL614589,
Cosmic:2491096,
Cosmic-CLP:1327768,
DepMap:ACH-000151,
EGA:EGAS00001000978,
GDSC:1327768,
GEO:GSM887186,
GEO:GSM888259,
GEO:GSM1669962,
IARC_TP53:30091,
IGRhCellID:JM1,
LiGeA:CCLE_153,
LINCS_LDP:LCL-1947,
PharmacoDB:JM1_709_2019,
PRIDE:PXD030304,
Progenetix:CVCL_3532,
PubChem_Cell_line:CVCL_3532,
Wikidata:Q54898988 |
|
|
CVCL_3532 |
2026-08-15 04:43:55 |
0 |
JMSU-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2081
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Karyotypic information: Has lost chromosome Y., Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7483139
PMID:22460905
PMID:24035680
PMID:24367658
PMID:26589293
PMID:29732388
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Male |
JMSU1 |
|
|
CLO:CLO_0050846,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:626,
BioSample:SAMN03472026,
BioSample:SAMN03473570,
BioSample:SAMN10988102,
cancercelllines:CVCL_2081,
Cell_Model_Passport:SIDM01587,
Cosmic:1285120,
Cosmic:2050446,
Cosmic:2057451,
Cosmic:2444245,
Cosmic:2686098,
DepMap:ACH-000753,
DSMZ:ACC-505,
DSMZCellDive:ACC-505,
FANTOM5_SSTAR:10492-107B6,
GEO:GSM887187,
GEO:GSM888260,
IARC_TP53:28279,
LiGeA:CCLE_366,
PharmacoDB:JMSU1_710_2019,
Progenetix:CVCL_2081,
RCB:RCB2227,
Wikidata:Q54899011 |
|
|
CVCL_2081 |
2026-08-15 04:43:56 |
5 |
JURL-MK1
Resource Report
Resource Website
|
RRID:CVCL_2086
|
Homo sapiens (Human)
|
Chronic myelogenous leukemia, BCR-ABL1 positive
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9305612
PMID:10071072
PMID:10576511
PMID:16408098
PMID:22460905
PMID:27397505
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
JURLMK1 |
|
|
BTO:BTO_0005909,
CLO:CLO_0009838,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473526,
BioSample:SAMN10988501,
cancercelllines:CVCL_2086,
Cell_Model_Passport:SIDM01015,
CGH-DB:9214-4,
Cosmic:1012073,
Cosmic:1078719,
Cosmic-CLP:1327771,
DepMap:ACH-000326,
DSMZ:ACC-532,
DSMZCellDive:ACC-532,
EGA:EGAS00001000978,
GDSC:1327771,
GEO:GSM887189,
GEO:GSM888262,
GEO:GSM1669966,
IARC_TP53:28238,
LiGeA:CCLE_124,
LINCS_LDP:LCL-1101,
PharmacoDB:JURLMK1_714_2019,
PRIDE:PXD030304,
Progenetix:CVCL_2086,
Wikidata:Q54899164 |
|
|
CVCL_2086 |
2026-08-15 04:44:02 |
0 |
Jurkat
Resource Report
Resource Website
5000+ mentions
Discontinued
|
RRID:CVCL_0065
|
Homo sapiens (Human)
|
Childhood T acute lymphoblastic leukemia
|
Anecdotal: Have been flown in space on Cosmos-2044 to study the inhibition of phorbol ester-induced cell activation in microgravity (PubMed=1915666)., Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: International Histocompatibility Workshop cell lines., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:68013
PMID:204546
PMID:1086134
PMID:1103999
PMID:1915666
PMID:2144611
PMID:2985879
PMID:3159941
PMID:3165345
PMID:3874327
PMID:8127147
PMID:8547074
PMID:8558913
PMID:8641406
PMID:8957066
PMID:9510473
PMID:9583678
PMID:9685479
PMID:9738977
PMID:9787181
PMID:9933131
PMID:10071127
PMID:10739008
PMID:11021758
PMID:11226526
PMID:15028022
PMID:15472075
PMID:16408098
PMID:17117183
PMID:17170727
PMID:19220422
PMID:19473701
PMID:19608861
PMID:22278370
PMID:22460905
PMID:22675565
PMID:22944676
PMID:23325432
PMID:24618588
PMID:26074081
PMID:27397505
PMID:28357668
PMID:29967540
PMID:30285677
PMID:30629668
PMID:30844424
PMID:30894373
PMID:31068700
PMID:31160637
PMID:31978347
PMID:35354797
PMID:35839778
|
Cancer cell line
|
Male |
JURKAT, JM, JM-Jurkat, Jurkat-FHCRC, Jurkat FHCRC, FHCRC-11, FHCRC subclone 11, FCCH1024 |
|
|
BTO:BTO_0000661,
CLO:CLO_0007029,
CLO:CLO_0007043,
CLO:CLO_0050978,
CLO:CLO_0050993,
CLO:CLO_0051001,
EFO:EFO_0002796,
MCCL:MCC:0000503,
CLDB:cl2950,
CLDB:cl2959,
CLDB:cl2960,
CLDB:cl2961,
CLDB:cl5212,
Abcam:ab271143,
Abcam:ab275468,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
BEI_Resources:ARP-4668,
BioGRID_ORCS_Cell_line:1255,
BioSample:SAMN03472181,
BioSample:SAMN03472286,
BioSample:SAMN03473341,
BioSample:SAMN10988565,
cancercelllines:CVCL_0065,
CCRID:1101HUM-PUMC000347,
Cell_Model_Passport:SIDM01016,
ChEMBL-Cells:CHEMBL3307526,
ChEMBL-Targets:CHEMBL397,
CLS:302147,
CLS:305018,
Cosmic:683539,
Cosmic:721707,
Cosmic:755289,
Cosmic:801727,
Cosmic:850196,
Cosmic:913426,
Cosmic:919152,
Cosmic:922675,
Cosmic:933540,
Cosmic:991544,
Cosmic:998737,
Cosmic:999757,
Cosmic:1012072,
Cosmic:1037693,
Cosmic:1115592,
Cosmic:1118463,
Cosmic:1118464,
Cosmic:1127262,
Cosmic:1130236,
Cosmic:1132774,
Cosmic:1175129,
Cosmic:1191689,
Cosmic:1224368,
Cosmic:1226860,
Cosmic:1330489,
Cosmic:1375588,
Cosmic:1483364,
Cosmic:1524798,
Cosmic:1639637,
Cosmic:1641380,
Cosmic:1664522,
Cosmic:1760524,
Cosmic:1811157,
Cosmic:2039520,
Cosmic:2165713,
Cosmic:2301569,
Cosmic:2361366,
Cosmic:2602916,
Cosmic:2750872,
Cosmic-CLP:998184,
DepMap:ACH-000995,
DSMZ:ACC-282,
DSMZCellDive:ACC-282,
ECACC:86010201,
EGA:EGAS00001000978,
EGA:EGAS00001002554,
FANTOM5_SSTAR:10464-106H5,
GDSC:998184,
GEO:GSM1991,
GEO:GSM236783,
GEO:GSM236819,
GEO:GSM482494,
GEO:GSM749672,
GEO:GSM887188,
GEO:GSM888261,
GEO:GSM1040307,
GEO:GSM1040377,
GEO:GSM1374580,
GEO:GSM1669965,
GEO:GSM5137718,
GEO:GSM5534218,
GEO:GSM5534219,
GEO:GSM5534220,
GEO:GSM5534221,
GEO:GSM5534222,
GEO:GSM5534223,
GEO:GSM7701387,
GEO:GSM7701388,
IARC_TP53:186,
IBRC:C10155,
ICLC:HTL01002,
IHW:IHW00002,
IZSLER:BS CL 131,
KCB:KCB 94018YJ,
LiGeA:CCLE_029,
LINCS_LDP:LCL-2107,
Lonza:142,
MeSH:D019169,
NCBI_Iran:C120,
PharmacoDB:JURKAT_712_2019,
PRIDE:PRD000008,
PRIDE:PRD000013,
PRIDE:PRD000787,
PRIDE:PXD000426,
PRIDE:PXD000443,
PRIDE:PXD001428,
PRIDE:PXD001872,
PRIDE:PXD002091,
PRIDE:PXD002395,
PRIDE:PXD006201,
PRIDE:PXD023662,
PRIDE:PXD030304,
Progenetix:CVCL_0065,
PubChem_Cell_line:CVCL_0065,
RCB:RCB0537,
RCB:RCB0806,
RCB:RCB3052,
TKG:TKG 0209,
TOKU-E:3710,
Wikidata:Q1632589 |
|
|
CVCL_0065 |
2026-08-15 04:44:01 |
8048 |
JVM-3
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1320
|
Homo sapiens (Human)
|
B-cell prolymphocytic leukemia
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3093393
PMID:3262465
PMID:20164919
PMID:20215515
PMID:20454443
PMID:22460905
PMID:26589293
PMID:27397505
PMID:29989027
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:31160637
PMID:35839778
|
Transformed cell line
|
Male |
JVM3 |
|
|
BTO:BTO_0006032,
CLO:CLO_0007048,
EFO:EFO_0002214,
CLDB:cl2966,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
BioSample:SAMN03473365,
BioSample:SAMN10988549,
cancercelllines:CVCL_1320,
Cell_Model_Passport:SIDM01012,
ChEMBL-Cells:CHEMBL3308203,
ChEMBL-Targets:CHEMBL2366372,
Cosmic:907270,
Cosmic:2756297,
Cosmic-CLP:907270,
DepMap:ACH-000346,
DSMZ:ACC-18,
DSMZCellDive:ACC-18,
EGA:EGAS00001000978,
GDSC:907270,
GEO:GSM887191,
GEO:GSM888264,
GEO:GSM1374582,
GEO:GSM1669968,
IARC_TP53:21423,
IGRhCellID:JVM3,
LiGeA:CCLE_187,
LINCS_LDP:LCL-1100,
PharmacoDB:JVM3_716_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1320,
PubChem_Cell_line:CVCL_1320,
Wikidata:Q54899193 |
|
|
CVCL_1320 |
2026-08-15 04:44:02 |
1 |
K5
Resource Report
Resource Website
Contaminated
|
RRID:CVCL_1322
|
Homo sapiens (Human)
|
Thyroid gland papillary carcinoma
|
Population: Caucasian; Italian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Shown to be a GLAG-66 derivative (STR profile and somatic mutations from Cosmic-CLP)..
|
PMID:10646882
PMID:20164919
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
|
|
|
CLO:CLO_0037154,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
cancercelllines:CVCL_1322,
Cell_Model_Passport:SIDM00056,
ChEMBL-Cells:CHEMBL3308144,
ChEMBL-Targets:CHEMBL2366152,
Cosmic:924238,
Cosmic:928832,
Cosmic:1162843,
Cosmic:1507370,
Cosmic:1533547,
Cosmic:1536123,
Cosmic:1789444,
Cosmic:1889002,
Cosmic:2791090,
Cosmic-CLP:924238,
DepMap:ACH-002148,
EGA:EGAS00001000978,
GDSC:924238,
GEO:GSM1669970,
IARC_TP53:27559,
LINCS_LDP:LCL-1692,
PharmacoDB:K5_724_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1322,
Wikidata:Q54899290 |
cvcl_9918 |
|
CVCL_1322 |
2026-08-15 04:44:05 |
0 |
K029AX
Resource Report
Resource Website
|
RRID:CVCL_8784
|
Homo sapiens (Human)
|
Cutaneous melanoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:22460905
PMID:26589293
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Sex unspecified |
|
|
|
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:720,
BioSample:SAMN10988224,
cancercelllines:CVCL_8784,
Cell_Model_Passport:SIDM01629,
DepMap:ACH-000404,
GEO:GSM887192,
GEO:GSM888265,
IARC_TP53:30092,
LiGeA:CCLE_591,
PharmacoDB:K029AX_718_2019,
Progenetix:CVCL_8784,
Wikidata:Q54899236 |
cvcl_5143 |
|
CVCL_8784 |
2026-08-15 04:44:03 |
0 |
Karpas-620
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_1823
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine., Characteristics: Produces IgG kappa., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2310698
PMID:10936422
PMID:11157491
PMID:16956823
PMID:17692805
PMID:18647998
PMID:19064000
PMID:21173094
PMID:22460905
PMID:25485619
PMID:25688540
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30285677
PMID:30545397
PMID:30894373
PMID:31068700
PMID:32123307
PMID:35839778
|
Cancer cell line
|
Female |
KARPAS-620, Karpas 620, KARPAS 620, Karpas620, KARPAS620, K620 |
|
|
CLO:CLO_0037176,
EFO:EFO_0006449,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-TABM-1088,
BioSample:SAMN03473162,
BioSample:SAMN10989552,
cancercelllines:CVCL_1823,
Cell_Model_Passport:SIDM01006,
Cosmic:720777,
Cosmic:2081387,
Cosmic:2131564,
Cosmic:2367275,
Cosmic:2809762,
Cosmic-CLP:1327775,
DepMap:ACH-000193,
DSMZ:ACC-514,
DSMZCellDive:ACC-514,
ECACC:22110802,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:EGAS00001002554,
GDSC:1327775,
GEO:GSM887196,
GEO:GSM888269,
GEO:GSM1374589,
GEO:GSM1669978,
IARC_TP53:28386,
LiGeA:CCLE_349,
LINCS_LDP:LCL-2053,
PharmacoDB:KARPAS620_732_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1823,
Wikidata:Q54899502,
Ximbio:152425 |
|
|
CVCL_1823 |
2026-08-15 04:44:10 |
3 |
KATO III
Resource Report
Resource Website
10+ mentions
Discontinued
|
RRID:CVCL_0371
|
Homo sapiens (Human)
|
Down syndrome
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: FGFR genetic alteration cell panel (ATCC TCP-1034)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:209229
PMID:1370612
PMID:1778766
PMID:1933850
PMID:3518877
PMID:3962675
PMID:6862145
PMID:9023415
PMID:9247707
PMID:9290701
PMID:11107048
PMID:11314020
PMID:15723654
PMID:17505008
PMID:20164919
PMID:20215515
PMID:22460905
PMID:24587255
PMID:24807215
PMID:25343454
PMID:25485619
PMID:25877200
PMID:25960936
PMID:26589293
PMID:27397505
PMID:28196595
PMID:29435981
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:32028591
PMID:35839778
|
Cancer cell line
|
Male |
Kato III, Kato-III, KATO-III, KATOIII, KatoIII, KATO 3, JTC-28, Japanese Tissue Culture-28 |
|
|
BTO:BTO_0001092,
CLO:CLO_0007073,
CLO:CLO_0050790,
EFO:EFO_0002217,
MCCL:MCC:0000266,
CLDB:cl3000,
CLDB:cl5214,
AddexBio:C0023001/53,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-103,
BCRC:60200,
BCRJ:0318,
BioGRID_ORCS_Cell_line:909,
BioSample:SAMN01821574,
BioSample:SAMN01821690,
BioSample:SAMN03471089,
BioSample:SAMN03473264,
BioSample:SAMN10988331,
cancercelllines:CVCL_0371,
CCRID:3101HUMSCSP573,
CCRID:3101HUMTCHu229,
CCTCC:GDC0253,
Cell_Model_Passport:SIDM00687,
CGH-DB:122-1,
CGH-DB:9024-4,
ChEMBL-Cells:CHEMBL3308432,
ChEMBL-Targets:CHEMBL612700,
CLS:300381,
Cosmic:685595,
Cosmic:687555,
Cosmic:755614,
Cosmic:801336,
Cosmic:848150,
Cosmic:848375,
Cosmic:877044,
Cosmic:887248,
Cosmic:888823,
Cosmic:889107,
Cosmic:907276,
Cosmic:922690,
Cosmic:926118,
Cosmic:968350,
Cosmic:1001657,
Cosmic:1067210,
Cosmic:1090464,
Cosmic:1093302,
Cosmic:1187279,
Cosmic:1223583,
Cosmic:1518254,
Cosmic:1571766,
Cosmic:1627262,
Cosmic:1890472,
Cosmic:2009529,
Cosmic:2036664,
Cosmic:2069771,
Cosmic:2484964,
Cosmic:2807629,
Cosmic:2823224,
Cosmic-CLP:907276,
DepMap:ACH-000793,
ECACC:86093004,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10436-106E4,
GDSC:907276,
GEO:GSM267419,
GEO:GSM267426,
GEO:GSM267433,
GEO:GSM267440,
GEO:GSM552362,
GEO:GSM562404,
GEO:GSM827547,
GEO:GSM828835,
GEO:GSM844573,
GEO:GSM887200,
GEO:GSM888273,
GEO:GSM1237676,
GEO:GSM1237701,
GEO:GSM1250898,
GEO:GSM1250899,
GEO:GSM1250900,
GEO:GSM1250901,
GEO:GSM1374593,
GEO:GSM1374594,
GEO:GSM1669980,
IARC_TP53:21648,
IGRhCellID:KATOIII,
IZSLER:BS TCL 151,
JCRB:JCRB0611,
JCRB:NIHS0052,
KCB:KCB 2014045YJ,
KCLB:30103,
LiGeA:CCLE_710,
LINCS_HMS:50022,
LINCS_LDP:LCL-2003,
NCBI_Iran:C640,
PharmacoDB:KATOIII_737_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0371,
PubChem_Cell_line:CVCL_0371,
RCB:RCB2088,
TKG:TKG 0213,
Wikidata:Q54899539 |
cvcl_m882 |
|
CVCL_0371 |
2026-08-15 04:44:10 |
35 |
MJ
Resource Report
Resource Website
1+ mentions
|
ATCC Cat# CRL-8294, RRID:CVCL_1414
|
Homo sapiens (Human)
|
Primary cutaneous T-cell non-Hodgkin lymphoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:6604130
PMID:7662981
PMID:20164919
PMID:20215515
PMID:22460905
PMID:25355872
PMID:26589293
PMID:30285677
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
G11 |
ATCC |
CRL-8294 |
CLO:CLO_0007731,
EFO:EFO_0002237,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ATCC:CRL-8294,
BCRC:60543,
BioSample:SAMN03471200,
BioSample:SAMN10987950,
cancercelllines:CVCL_1414,
Cell_Model_Passport:SIDM01692,
Cosmic:908137,
DepMap:ACH-000077,
GEO:GSM887322,
GEO:GSM888398,
IARC_TP53:21504,
IGRhCellID:MJ,
LiGeA:CCLE_874,
LINCS_LDP:LCL-1142,
PharmacoDB:MJ_933_2019,
Progenetix:CVCL_1414,
Wikidata:Q54905784 |
|
|
CVCL_1414 |
2026-08-15 04:46:26 |
4 |
MKN1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1415
|
Homo sapiens (Human)
|
Gastric adenosquamous carcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:758928
PMID:1370612
PMID:1778766
PMID:1933850
PMID:6862145
PMID:9290701
PMID:11107048
PMID:15723654
PMID:15767549
PMID:15900046
PMID:20164919
PMID:20215515
PMID:22336246
PMID:22460905
PMID:24807215
PMID:25343454
PMID:25485619
PMID:25877200
PMID:25960936
PMID:26589293
PMID:27397505
PMID:28196595
PMID:29435981
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:32847597
PMID:34331011
|
Cancer cell line
|
Male |
MKN-1, MKN 1 |
|
|
BTO:BTO_0002384,
CLO:CLO_0050804,
EFO:EFO_0002830,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473129,
BioSample:SAMN10987827,
cancercelllines:CVCL_1415,
Cell_Model_Passport:SIDM00271,
CGH-DB:117-1,
CGH-DB:9019-4,
ChEMBL-Cells:CHEMBL3307492,
ChEMBL-Targets:CHEMBL614352,
Cosmic:733174,
Cosmic:801337,
Cosmic:848145,
Cosmic:848379,
Cosmic:887252,
Cosmic:888824,
Cosmic:897532,
Cosmic:908138,
Cosmic:922692,
Cosmic:926111,
Cosmic:1007600,
Cosmic:1090459,
Cosmic:1093296,
Cosmic:1187282,
Cosmic:1223586,
Cosmic:1436023,
Cosmic:1482076,
Cosmic:1627263,
Cosmic:1995508,
Cosmic:2443801,
Cosmic:2484957,
Cosmic:2807632,
Cosmic-CLP:908138,
DepMap:ACH-000351,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10614-108G2,
GDSC:908138,
GEO:GSM552363,
GEO:GSM562394,
GEO:GSM827531,
GEO:GSM844606,
GEO:GSM887323,
GEO:GSM888399,
GEO:GSM1374680,
GEO:GSM1670111,
IARC_TP53:998,
JCRB:JCRB0252,
KCLB:80101,
LiGeA:CCLE_128,
LINCS_LDP:LCL-1917,
Lonza:1374,
PharmacoDB:MKN1_936_2019,
Progenetix:CVCL_1415,
PubChem_Cell_line:CVCL_1415,
RCB:RCB1003,
Wikidata:Q54905820 |
|
|
CVCL_1415 |
2026-08-15 04:46:31 |
22 |
MKN45
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0434
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Caution: Was indicated not to have a TP53 mutation in PubMed=1370612 and PubMed=15900046., Characteristics: MET-amplified, contains 12-13 copies of the gene (PubMed=29435981)., Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:758928
PMID:1370612
PMID:1486568
PMID:1778766
PMID:1846553
PMID:1933850
PMID:2061947
PMID:2105279
PMID:3962675
PMID:3986962
PMID:6862145
PMID:9023415
PMID:9247707
PMID:9290701
PMID:9665481
PMID:11107048
PMID:11314020
PMID:11668190
PMID:15723654
PMID:15767549
PMID:15900046
PMID:15901131
PMID:18804159
PMID:20164919
PMID:20215515
PMID:22336246
PMID:22460905
PMID:22531121
PMID:23671654
PMID:24587255
PMID:24807215
PMID:25343454
PMID:25485619
PMID:25877200
PMID:25960936
PMID:26589293
PMID:27397505
PMID:28196595
PMID:29435981
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Female |
MKN-45, MKN 45 |
|
|
BTO:BTO_0001225,
CLO:CLO_0007733,
CLO:CLO_0050797,
EFO:EFO_0002832,
MCCL:MCC:0000329,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:404,
BioSample:SAMN03473237,
BioSample:SAMN03473585,
BioSample:SAMN10988555,
cancercelllines:CVCL_0434,
CCRID:1101HUM-PUMC000229,
CCTCC:GDC0220,
Cell_Model_Passport:SIDM00247,
CGH-DB:120-1,
CGH-DB:9022-4,
ChEMBL-Cells:CHEMBL3307603,
ChEMBL-Targets:CHEMBL614354,
CLS:300489,
Cosmic:685596,
Cosmic:801339,
Cosmic:848147,
Cosmic:848373,
Cosmic:873711,
Cosmic:877042,
Cosmic:887256,
Cosmic:888827,
Cosmic:897535,
Cosmic:918497,
Cosmic:922696,
Cosmic:925340,
Cosmic:926114,
Cosmic:968349,
Cosmic:983727,
Cosmic:1001651,
Cosmic:1001655,
Cosmic:1007602,
Cosmic:1090461,
Cosmic:1093299,
Cosmic:1187283,
Cosmic:1223589,
Cosmic:1329185,
Cosmic:1436026,
Cosmic:1460707,
Cosmic:1518241,
Cosmic:1518255,
Cosmic:1582430,
Cosmic:1627265,
Cosmic:1995510,
Cosmic:2036663,
Cosmic:2807633,
Cosmic:2823225,
Cosmic-CLP:925340,
DepMap:ACH-000356,
DSMZ:ACC-409,
DSMZCellDive:ACC-409,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10612-108F9,
GDSC:925340,
GEO:GSM552364,
GEO:GSM562395,
GEO:GSM618013,
GEO:GSM618014,
GEO:GSM618015,
GEO:GSM618016,
GEO:GSM827532,
GEO:GSM828836,
GEO:GSM844607,
GEO:GSM887324,
GEO:GSM888400,
GEO:GSM1374681,
GEO:GSM1670113,
IARC_TP53:21633,
IARC_TP53:30213,
IBRC:C10137,
JCRB:JCRB0254,
KCLB:80103,
LiGeA:CCLE_725,
LINCS_LDP:LCL-1535,
NCBI_Iran:C615,
PharmacoDB:MKN45_938_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0434,
PubChem_Cell_line:CVCL_0434,
RCB:RCB1001,
Wikidata:Q28473066 |
|
|
CVCL_0434 |
2026-08-15 04:46:28 |
974 |
MKN28
Resource Report
Resource Website
10+ mentions
Contaminated
Discontinued
Discontinued
Discontinued
Discontinued
|
RRID:CVCL_1416
|
Homo sapiens (Human)
|
Gastric tubular adenocarcinoma
|
Population: Japanese., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Shown to be a MKN74 derivative (PubMed=20143388)..
|
PMID:758928
PMID:1370612
PMID:1933850
PMID:3962675
PMID:3986962
PMID:6862145
PMID:9023415
PMID:9290701
PMID:11107048
PMID:11314020
PMID:15723654
PMID:15767549
PMID:15900046
PMID:15901131
PMID:20143388
PMID:20164919
PMID:22336246
PMID:22490663
PMID:23671654
PMID:25960936
PMID:27397505
PMID:29435981
PMID:29717028
PMID:30894373
PMID:30971826
PMID:35839778
|
Cancer cell line
|
Male |
MKN-28, MKN 28 |
|
|
BTO:BTO_0002381,
CLO:CLO_0037142,
EFO:EFO_0002831,
ABM:T9192,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:944,
BioSample:SAMN03151847,
cancercelllines:CVCL_1416,
Cell_Model_Passport:SIDM00260,
CGH-DB:119-1,
CGH-DB:9021-4,
ChEMBL-Cells:CHEMBL3307602,
ChEMBL-Targets:CHEMBL614353,
Cosmic:801338,
Cosmic:848146,
Cosmic:848371,
Cosmic:873710,
Cosmic:875905,
Cosmic:877041,
Cosmic:887249,
Cosmic:888826,
Cosmic:897534,
Cosmic:908139,
Cosmic:918496,
Cosmic:922694,
Cosmic:926113,
Cosmic:968348,
Cosmic:983726,
Cosmic:1066230,
Cosmic:1067208,
Cosmic:1090460,
Cosmic:1093298,
Cosmic:1223588,
Cosmic:1436025,
Cosmic:1460710,
Cosmic:1482081,
Cosmic:1627264,
Cosmic:1995509,
Cosmic:2036660,
Cosmic:2069778,
Cosmic:2823226,
Cosmic-CLP:908139,
DepMap:ACH-002161,
EGA:EGAS00001000978,
GDSC:908139,
GEO:GSM562396,
GEO:GSM1670112,
IARC_TP53:972,
IARC_TP53:21505,
JCRB:FDSC0011,
JCRB:JCRB0253,
JCRB:NIHS0324,
JCRB:NIHS0325,
KCLB:80102,
LINCS_LDP:LCL-1922,
PharmacoDB:MKN28_937_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1416,
PubChem_Cell_line:CVCL_1416,
RCB:RCB1000,
Wikidata:Q54905823 |
cvcl_2791 |
|
CVCL_1416 |
2026-08-15 04:46:28 |
17 |
MM1.S
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_8792
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Characteristics: Sensitive to dexamethasone., Characteristics: Produces IgA lambda (ATCC=CRL-2974)., Population: African American., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:12691914
PMID:14760100
PMID:16956823
PMID:17692805
PMID:18647998
PMID:21173094
PMID:22460905
PMID:25485619
PMID:25688540
PMID:25877200
PMID:25984343
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30285677
PMID:30545397
PMID:30894373
PMID:30971826
PMID:31068700
PMID:32123307
PMID:35839778
|
Cancer cell line
|
Female |
MM.1S, MM1-S, MM-1S, MM1S |
|
|
BTO:BTO_0003933,
CLO:CLO_0037203,
EFO:EFO_0005724,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-TABM-1088,
ATCC:CRL-2974,
BioGRID_ORCS_Cell_line:801,
BioSample:SAMN03471684,
BioSample:SAMN10988254,
cancercelllines:CVCL_8792,
CCRID:1101HUM-PUMC000680,
CCRID:3101HUMSCSP5017,
Cell_Model_Passport:SIDM01265,
ChEMBL-Cells:CHEMBL4295490,
ChEMBL-Targets:CHEMBL4296471,
CLS:305304,
Cosmic:1424218,
Cosmic:1483077,
Cosmic:1762460,
Cosmic:1889512,
Cosmic:2081430,
Cosmic:2391805,
Cosmic:2809756,
Cosmic-CLP:1659818,
DepMap:ACH-000763,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
ENCODE:ENCBS205VYW,
ENCODE:ENCBS241TLI,
ENCODE:ENCBS299YQN,
ENCODE:ENCBS523NFL,
ENCODE:ENCBS981ZAE,
GDSC:1659818,
GEO:GSM562814,
GEO:GSM887328,
GEO:GSM888404,
GEO:GSM1374685,
GEO:GSM1666388,
GEO:GSM1670118,
IARC_TP53:28513,
IZSLER:BS TCL 237,
LiGeA:CCLE_132,
Lonza:168,
PharmacoDB:MM1S_944_2019,
PRIDE:PXD021265,
PRIDE:PXD030304,
Progenetix:CVCL_8792,
PubChem_Cell_line:CVCL_8792,
Wikidata:Q54906038 |
cvcl_5801 |
|
CVCL_8792 |
2026-08-15 04:46:35 |
261 |
MN-60
Resource Report
Resource Website
|
RRID:CVCL_1421
|
Homo sapiens (Human)
|
Burkitt lymphoma
|
Virology: EBV-negative., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6296550
PMID:15843827
PMID:16408098
PMID:20164919
PMID:24590883
PMID:27397505
PMID:28196595
PMID:30894373
PMID:31068700
PMID:35354797
PMID:35839778
|
Cancer cell line
|
Male |
MN 60, MN60 |
|
|
CLO:CLO_0007808,
CLDB:cl3506,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473415,
cancercelllines:CVCL_1421,
Cell_Model_Passport:SIDM00438,
ChEMBL-Cells:CHEMBL3308532,
ChEMBL-Targets:CHEMBL2366070,
Cosmic:908143,
Cosmic:1012093,
Cosmic-CLP:908143,
DepMap:ACH-002275,
DSMZ:ACC-138,
DSMZCellDive:ACC-138,
EGA:EGAS00001000978,
GDSC:908143,
GEO:GSM1670120,
GEO:GSM5137727,
IARC_TP53:21509,
LINCS_LDP:LCL-1010,
PharmacoDB:MN60_946_2019,
PRIDE:PXD023662,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1421,
Wikidata:Q54906259 |
|
|
CVCL_1421 |
2026-08-15 04:46:38 |
0 |
Mo
Resource Report
Resource Website
1+ mentions
|
ATCC Cat# CRL-8066, RRID:CVCL_1439
|
Homo sapiens (Human)
|
Hairy cell leukemia
|
Anecdotal: John Moore, the patient from which this cell line is derived, sued David Golde and the University of California over the patent that they deposited on the Mo cell line. Although his claims of ownership were rejected, his physician was deemed to have breached his fiduciary duty by not informing Moore of the economic and financial interests arising from the derivation of the cell line., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:305224
PMID:6600440
PMID:6981847
PMID:6984393
PMID:6987658
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
MO, Mo-T, Mo T, MoT, MOT |
ATCC |
CRL-8066 |
BTO:BTO_0001014,
CLO:CLO_0007815,
CLO:CLO_0037184,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-8066,
BioSample:SAMN03471131,
cancercelllines:CVCL_1439,
Cell_Model_Passport:SIDM00623,
ChEMBL-Cells:CHEMBL3308631,
ChEMBL-Targets:CHEMBL614722,
Cosmic:683660,
Cosmic:908149,
Cosmic:1120712,
Cosmic-CLP:908149,
DepMap:ACH-002339,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10712-109I1,
GDSC:908149,
GEO:GSM1670121,
GEO:GSM1670131,
IARC_TP53:21525,
LINCS_LDP:LCL-1096,
Lonza:1308,
PharmacoDB:MoT_947_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1439,
Wikidata:Q54906275 |
|
|
CVCL_1439 |
2026-08-15 04:46:39 |
2 |
Mo
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1439
|
Homo sapiens (Human)
|
Hairy cell leukemia
|
Anecdotal: John Moore, the patient from which this cell line is derived, sued David Golde and the University of California over the patent that they deposited on the Mo cell line. Although his claims of ownership were rejected, his physician was deemed to have breached his fiduciary duty by not informing Moore of the economic and financial interests arising from the derivation of the cell line., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:305224
PMID:6600440
PMID:6981847
PMID:6984393
PMID:6987658
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
MO, Mo-T, Mo T, MoT, MOT |
|
|
BTO:BTO_0001014,
CLO:CLO_0007815,
CLO:CLO_0037184,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-8066,
BioSample:SAMN03471131,
cancercelllines:CVCL_1439,
Cell_Model_Passport:SIDM00623,
ChEMBL-Cells:CHEMBL3308631,
ChEMBL-Targets:CHEMBL614722,
Cosmic:683660,
Cosmic:908149,
Cosmic:1120712,
Cosmic-CLP:908149,
DepMap:ACH-002339,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10712-109I1,
GDSC:908149,
GEO:GSM1670121,
GEO:GSM1670131,
IARC_TP53:21525,
LINCS_LDP:LCL-1096,
Lonza:1308,
PharmacoDB:MoT_947_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1439,
Wikidata:Q54906275 |
|
|
CVCL_1439 |
2026-08-15 04:46:39 |
2 |
MOLP-2
Resource Report
Resource Website
|
RRID:CVCL_2123
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Characteristics: Produces IgD lambda., Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8148313
PMID:10936422
PMID:15215163
PMID:22460905
PMID:25485619
PMID:25877200
PMID:26589293
PMID:30285677
PMID:30894373
PMID:31068700
PMID:32123307
|
Cancer cell line
|
Male |
MOLP2 |
|
|
EFO:EFO_0006653,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
BioSample:SAMN03472938,
BioSample:SAMN10988424,
cancercelllines:CVCL_2123,
Cell_Model_Passport:SIDM01690,
CGH-DB:9146-4,
DepMap:ACH-000453,
DSMZ:ACC-607,
DSMZCellDive:ACC-607,
EGA:EGAS00001000610,
GEO:GSM562815,
GEO:GSM887332,
GEO:GSM888408,
IARC_TP53:28365,
JCRB:JCRB1820,
LiGeA:CCLE_676,
PharmacoDB:MOLP2_953_2019,
Progenetix:CVCL_2123,
Wikidata:Q54906334 |
|
|
CVCL_2123 |
2026-08-15 04:46:40 |
0 |
MOLT-16
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1424
|
Homo sapiens (Human)
|
Childhood T acute lymphoblastic leukemia
|
Caution: TP53 mutations indicated to be at p.Met237Arg (c.710T>G) and p.Gly244Cys (c.730G>T) (PubMed=2144611)., Population: African American., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2144611
PMID:2784121
PMID:9408752
PMID:9510473
PMID:9933131
PMID:10739008
PMID:11226526
PMID:15472075
PMID:15843827
PMID:17170727
PMID:20164919
PMID:20215515
PMID:22460905
PMID:22675565
PMID:26589293
PMID:27397505
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:35354797
PMID:35839778
|
Cancer cell line
|
Female |
Molt-16, MOLT 16, MOLT16, Molt16 |
|
|
BTO:BTO_0004173,
EFO:EFO_0002239,
CLDB:cl3516,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473343,
BioSample:SAMN10988570,
cancercelllines:CVCL_1424,
Cell_Model_Passport:SIDM00431,
ChEMBL-Cells:CHEMBL3308271,
ChEMBL-Targets:CHEMBL2366362,
Cosmic:908147,
Cosmic:913425,
Cosmic:919155,
Cosmic:922678,
Cosmic:998725,
Cosmic:1115601,
Cosmic:1151787,
Cosmic:1226859,
Cosmic:1281380,
Cosmic:1330491,
Cosmic:1641382,
Cosmic:1760528,
Cosmic:2458764,
Cosmic:2462862,
Cosmic:2602927,
Cosmic-CLP:908147,
DepMap:ACH-000918,
DSMZ:ACC-29,
DSMZCellDive:ACC-29,
EGA:EGAS00001000978,
GDSC:908147,
GEO:GSM887335,
GEO:GSM888411,
GEO:GSM1670127,
GEO:GSM5137729,
IARC_TP53:187,
IARC_TP53:21513,
IGRhCellID:MOLT16,
LiGeA:CCLE_638,
LINCS_LDP:LCL-1018,
Lonza:2,
MetaboLights:MTBLS789,
PharmacoDB:MOLT16_956_2019,
PRIDE:PXD023662,
PRIDE:PXD030304,
Progenetix:CVCL_1424,
PubChem_Cell_line:CVCL_1424,
Wikidata:Q54906347 |
|
|
CVCL_1424 |
2026-08-15 04:46:40 |
3 |
